Rancom Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
- Satisfied Charges ₹ 9.00 Cr
- Revenue Growth -7.60%
- Profit Growth -1462.94%
- Ebitda -220.90%
- Net Worth -103.64%
- Total Assets 54.78%
About Rancom Healthcare
Rancom Healthcare Private Limited (RHPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 20 September 2012 and has a history of 12 years and five months. Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹9.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mahinder Singh and Shashi Verma serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51101UP2012PTC052648
- Company No.
052648
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2012
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Rancom Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahinder Singh  | Director | 27-Sep-2021 | Current |
| Shashi Verma | Director | 27-Sep-2021 | Current |
Financial Performance of Rancom Healthcare.
Rancom Healthcare Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 7.6% decrease. The company also saw a substantial fall in profitability, with a 1462.94% decrease in profit. The company's net worth observed a substantial decline by a decrease of 103.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rancom Healthcare?
In 2021, Rancom Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹90.00 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 5.00 Cr
- Others : 4.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 May 2017 | Hdfc Bank Limited | ₹5.00 Cr | Satisfied |
| 13 Aug 2014 | Others | ₹4.00 Cr | Satisfied |
How Many Employees Work at Rancom Healthcare?
Unlock and access historical data on people associated with Rancom Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rancom Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rancom Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
